Publications

Dynamics of asymptomatic Plasmodium falciparum and Plasmodium vivax infections and their infectiousness to mosquitoes in a low transmission setting of Ethiopia: a longitudinal observational study.

Hailemeskel, E; Tebeje, SK; Ramjith, J; Ashine, T; Lanke, K; Behaksra, SW; Emiru, T; Tsegaye, T; Gashaw, A; Kedir, S; Chali, W; Esayas, E; Tafesse, T; Abera, H; BULTO, MG; Shumie, G; Petros, B; Mamo, H; DRAKELEY, C; Gadisa, E; Bousema, T; Tadesse, FG;

2024

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases (2024). 10.1016/j.ijid.2024.107010.

Malaria elimination and the need for intensive inter-country cooperation. a critical evaluation of regional technical co-operation in Southern Africa.

Sikaala, CH; Dlamini, B; Lungu, A; Fakudze, P; Chisenga, M; Siame, CL; Mwendera, N; Shaba, D; Chimumbwa, JM; KLEINSCHMIDT, I;

2024

Malaria journal, (2024).23 1 10.1186/s12936-024-04891-5.

Risk factors for non-participation in ivermectin and dihydroartemisinin-piperaquine mass drug administration for malaria control in the MASSIV trial.

Kositz, C; VASILEVA, H; MOHAMMED, N; Achan, J; Dabira, ED; D'ALESSANDRO, U; BRADLEY, J; MARKS, M;

2024

Malaria journal, (2024).23 1 10.1186/s12936-024-04878-2.

Comparison of prevalence estimates of pfhrp2 and pfhrp3 deletions in Plasmodium falciparum determined by conventional PCR and multiplex qPCR and implications for surveillance and monitoring.

Gatton, ML; Smith, D; Pasay, C; Anderson, K; Mihreteab, S; Valdivia, HO; Sanchez, JF; BESHIR, KB; Cunningham, J; Cheng, Q;

2024

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, (2024).144, 10.1016/j.ijid.2024.107061.

Correction: Testing and treatment for malaria elimination: a systematic review.

Newby, G; Cotter, C; Roh, ME; Harvard, K; Bennett, A; Hwang, J; Chitnis, N; Fine, S; Stresman, G; Chen, I; GOSLING, R; Hsiang, MS;

2024

Malaria journal, (2024).23 1 10.1186/s12936-024-04861-x.

Is Brazil reaching malaria elimination? A time series analysis of malaria cases from 2011 to 2023.

Garcia, KK S; Soremekun, S; Abrahão, AA; Marchesini, PB; DRAKELEY, C; Ramalho, WM; Siqueira, AM;

2024

PLOS Global Public Health, (2024).4 1 10.1371/journal.pgph.0002845.

Kinetic properties of the recombinantly expressed PfPKGWT, PfPKGY214, PfPKGSTmut, PfPKGT695A, PfPKGT695E and CD analysis of PfPKGWT and PfPKGSTmut.

Koussis, K; Haase, S; Withers-Martinez, C; Flynn, HR; Kunzelmann, S; Christodoulou, E; Ibrahim, F; Skehel, M; BAKER, DA; Blackman, MJ;

2024

, PLOS Pathogens (2024).

Phenotypic evidence of deltamethrin resistance and identification of selective sweeps in Anopheles mosquitoes on the Bijagós Archipelago, Guinea-Bissau.

MOSS, S; JONES, RT; Pretorius, E; Da Silva, ET; Higgins, M; KRISTAN, M; Acford-Palmer, H; COLLINS, EL; Rodrigues, A; Krishna, S; CLARK, TG; LAST, A; CAMPINO, S;

2024

Scientific reports, (2024).14 1 10.1038/s41598-024-73996-3.

Malaria prevalence and transmission in the Zakpota sub-district of central Benin: baseline characteristics for a community randomised trial of a new insecticide for indoor residual spraying.

Govoetchan, R; Fongnikin, A; Hueha, C; Ahoga, J; Boko, C; Syme, T; Issiakou, R; Agbevo, A; Aikpon, R; Small, G; Snetselaar, J; Ossè, R; Tokponnon, F; Padonou, GG; NGUFOR, C;

2024

Parasites & vectors, (2024).17 1 10.1186/s13071-024-06342-1.

Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial.

Datoo, MS; Dicko, A; Tinto, H; Ouédraogo, J-B; Hamaluba, M; Olotu, A; BEAUMONT, E; Ramos Lopez, F; Natama, HM; Weston, S; Chemba, M; Compaore, YD; Issiaka, D; Salou, D; Some, AM; Omenda, S; Lawrie, A; Bejon, P; Rao, H; CHANDRAMOHAN, D; Roberts, R; Bharati, S; Stockdale, L; Gairola, S; GREENWOOD, BM; ... R21/Matrix-M Phase 3 Trial Group,

2024

Lancet (London, England), (2024).403 10426 10.1016/s0140-6736(23)02511-4.